ArticleTherapeutic advances in respiratory disease

Association of dipeptidyl peptidase-4 inhibitor use and the risk of asthma development among type 2 diabetes patients.

Peng-Fei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.